Tengsheng Pharmaceutical-B (02137) issued an announcement. On March 28, 2024, the company purchased shares in accordance with 2023...
According to Zhitong Finance App, Tengsheng BioPharmaceutical-B (02137) issued an announcement. On March 28, 2024, the company granted a total of 5.752,500 share purchase rights to 55 share purchase rights under the terms of the 2023 share purchase plan, and granted a total of 821,500 restricted share units to 18 restricted share unit grantees in accordance with the terms of the 2023 share award plan.